Table 2. Treatment effects at 2 weeks post-PRK.
anti-TGFβ (n=4) | controls (n=7) | |
---|---|---|
M (spherical equivalent) [D] | 4.79 ±0.86 (4.04 to 5.68) |
5.04 ±2.11 (2.56 to 7.65) |
J0 (0/90° astigmatism) [D] | 0.09 ±0.09 (−0.03 to 0.20) |
0.27 ±0.48 (−0.38 to 0.84) |
J45 (45/135° astigmatism)[D] | 0.20 ±0.13 (0.05 to 0.37) |
0.30 ±0.52 (−0.20 to 1.14) |
total HOA RMS [μm] |
0.20±0.18† (0.036 to 0.362) |
0.82±0.32 (0.477 to 1.232) |
coma RMS [μm] |
0.08 ±0.28* (−0.13 to 0.46) |
0.48 ±0.22 (0.17 to 0.71) |
spherical aberration RMS [μm] | 0.21 ±0.07 (0.139 to 0.279) |
0.41 ±0.40 (−0.136 to 1.001) |
residual HOA RMS [μm] |
0.06 ±0.1† (−0.025 to 0.201) |
0.49 ±0.27 (0.196 to 0.874) |
6th to 10th order RMS [μm] | 0.01 ±0.01 (−0.022 to 0.297) |
0.10 ±0.09 (0.014 to 0.235) |
log BCVSOTF | −0.27 ±0.34 (−0.65 to 0.18) |
−0.67 ±0.27 (−1.15 to −0.46) |
P <0.05 (inter-group differences Student's t test)
P <0.01 (inter-group differences Student's t test)
BCVSOTF: visual Strehl ratio, based on the optical transfer function (simulation for best spectacle correction)
total RMS: RMS of 2nd to 5th order aberrations
HOA RMS: RMS of 3rd to 5th order aberrations
coma RMS: RMS of 3rd and 5th order coma terms
residual HOA RMS: RMS of all non-coma, non-spherical HOA